Enjoying Breathing Program: A National Prospective Study Protocol to Improve Chronic Obstructive Pulmonary Disease Management in Chinese Primary Health Care

References

• VosT, AllenC, AroraM; Collaborators GDaIIaP. Global, regional, and national incidence, prevalence, and year lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602. doi:10.1016/S0140-6736(16)31678-627733282
   PubMed Web of Science ®Google Scholar
• SorianoJB, AbajobirAA, AbateKH; Collaborators GCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and year lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706. doi:10.1016/S2213-2600(17)30293-X28822787
   PubMed Web of Science ®Google Scholar
• HalbertRJ, IsonakaS, GeorgeD, IqbalA. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123:1684–1692. doi:10.1378/chest.123.5.168412740290
   PubMed Web of Science ®Google Scholar
• WangC, XuJ, YangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706–1717. doi:10.1016/S0140-6736(18)30841-929650248
   PubMed Web of Science ®Google Scholar
• ManninoDM. A Sonia B. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–773. doi:10.1016/S0140-6736(07)61380-417765526
   PubMed Web of Science ®Google Scholar
• ChanKY, LiX, ChenW, et al. Prevalence of chronic obstructive pulmonary disease (COPD) in China in 1990 and 2010. J Glob Health. 2017;7:020704. doi:10.7189/jogh.07.02070429423187
   PubMed Web of Science ®Google Scholar
• MiravitllesM, RiberaA. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18:67. doi:10.1186/s12931-017-0548-328431503
   PubMed Web of Science ®Google Scholar
• YinP, WangH, VosT, et al. A subnational analysis for mortality and prevalence of chronic obstructive pulmonary disease in China 1990–2013: findings from Global Burden of Disease Study (GBD) 2013. Chest. 2016;150:1269–1280. doi:10.1016/j.chest.2016.08.147427693597
   PubMed Web of Science ®Google Scholar
• MurrayCJ, LopezAD. Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997;349:1498–1504. doi:10.1016/S0140-6736(96)07492-29167458
   PubMed Web of Science ®Google Scholar
• YangH, WangH, DuL, WangY, WangX, ZhangR. Disease knowledge and self-management behavior of COPD patients in China. Medicine. 2019;98:e14460. doi:10.1097/MD.000000000001446030813148
   PubMed Web of Science ®Google Scholar
• HowcroftM, WaltersEH, Wood-BakerR, WaltersJA. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12:CD005074. doi:10.1002/14651858.CD003091.pub427990628
   PubMed Web of Science ®Google Scholar
• RussellS, OgunbayoOJ, NewhamJJ, et al. Qualitative systematic review of barriers and facilitators to self-management of chronic obstructive pulmonary disease: views of patients and healthcare professionals. Npj Prim Care Respir Med. 2018;28:2. doi:10.1038/s41533-017-0069-z29343739
   PubMed Web of Science ®Google Scholar
• KorpershoekYJ, SlotJCB, EffingTW, SchuurmansMJ, TrappenburgJC. Self-management behaviors to reduce exacerbation impact in COPD patients: a Delphi study. Int J Chron Obstruct Pulmon Dis. 2017;12:2735–2746. doi:10.2147/COPD.S13886728979116
   PubMed Web of Science ®Google Scholar
• BoerGMD, MennemaTH, NoortEV, ChavannesNH, BirnieE, VeenJ. Intrinsic factors influence self-management participation in COPD: effects on self-efficacy. Erj Open Res. 2018;4:00011–2018. doi:10.1183/23120541.00011-201829900178
   PubMedGoogle Scholar
• GuanWJ, RanPX, ZhongNS. Prevention and management of COPD in China: successes and major challenges. Lancet Respir Med. 2016;4:428–430. doi:10.1016/S2213-2600(16)30092-327185522
   PubMed Web of Science ®Google Scholar
• ZhangRB. Awareness of knowledge of COPD by Doctors in District and Community Hospitals. Chin J Prev Control Chron Non-Commun Dis. 2009;17(1):61–63.
   Google Scholar
• Bo ZPP, SinanW, YongZ, et al. Chronic respiratory disease management in grassroots medical institutions of China. Chin Gen Pract. 2018;21:1513–1520.
   Google Scholar
• XU YangZP, TingY, ChenW. Current status of prevention and control of chronic obstructive pulmonary disease in primary care in China. Chin Gen Pract. 2016;19:4153–4158.
   Google Scholar
• MachinD, CampbellMJ, TanSB, TanSH. Sample Size Tables for Clinical Studies. 3rd ed. Wiley-Blackwell; 2011.
   Google Scholar
• LiuH, WuT. Sample size calculation and power analysis of time-averaged difference. J Mod Appl Stat Meth. 2005;4:434–445. doi:10.22237/jmasm/1130803680
   Google Scholar
• ZhouYM, ChenSY, TianJ, et al. Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. Int J Tuberc Lung Dis. 2013;17:1645–1651. doi:10.5588/ijtld.12.099524200283
   PubMed Web of Science ®Google Scholar
• JonesPW, HardingG, BerryP, WiklundI, ChenWH, LeidyNK. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648–654. doi:10.1183/09031936.0010250919720809
   PubMed Web of Science ®Google Scholar
• MahlerDA, WellsCK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:(3):580–586.3342669
   PubMed Web of Science ®Google Scholar
• HerdmanM, GudexC, LloydA. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research. 2011;20:(10):1727–1736.21479777
   PubMed Web of Science ®Google Scholar
• ThomsenM, NordestgaardBG, VestboJ, LangeP. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med. 2013;1:543–550. doi:10.1016/S2213-2600(13)70137-124461615
   PubMed Web of Science ®Google Scholar
• JanssenMF, PickardAS, GolickiD, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22:1717–1727. doi:10.1007/s11136-012-0322-423184421
   PubMed Web of Science ®Google Scholar
• National Health and Family Planning Commision of the People's Republic of China. The 13th Five Year Plan for Healthcare; 2016 Available from: http://www.gov.cn/zhengce/content/2017.01/10/content_5158488.htm. Accessed 11, 2020.
   Google Scholar
• HanMLK. Clinical correlations of computed tomography imaging in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10:S131–S137. doi:10.1513/AnnalsATS.201303-046AW24313763
   PubMedGoogle Scholar
• EisnerMD, BlancPD, YelinEH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med. 2008;121:789–796. doi:10.1016/j.amjmed.2008.04.03018724969
   PubMed Web of Science ®Google Scholar